223 related articles for article (PubMed ID: 26209800)
1. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
[TBL] [Abstract][Full Text] [Related]
2. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
3. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
4. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
5. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
[TBL] [Abstract][Full Text] [Related]
6. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Pavel AB; Vasile CI
J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
[TBL] [Abstract][Full Text] [Related]
8. Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.
Liu H; Xing Y; Yang S; Tian D
Oncol Rep; 2011 Dec; 26(6):1539-46. PubMed ID: 21887471
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial patterns of somatic gene mutations in cancer.
Yeang CH; McCormick F; Levine A
FASEB J; 2008 Aug; 22(8):2605-22. PubMed ID: 18434431
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
11. Cancer genes.
Vogt PK
West J Med; 1993 Mar; 158(3):273-8. PubMed ID: 8460509
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical HotNet: identifying hierarchies of altered subnetworks.
Reyna MA; Leiserson MDM; Raphael BJ
Bioinformatics; 2018 Sep; 34(17):i972-i980. PubMed ID: 30423088
[TBL] [Abstract][Full Text] [Related]
13. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
[TBL] [Abstract][Full Text] [Related]
14. Novel ratio-metric features enable the identification of new driver genes across cancer types.
Sudhakar M; Rengaswamy R; Raman K
Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the evaluation of cancer driver genes.
Tokheim CJ; Papadopoulos N; Kinzler KW; Vogelstein B; Karchin R
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14330-14335. PubMed ID: 27911828
[TBL] [Abstract][Full Text] [Related]
16. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
[TBL] [Abstract][Full Text] [Related]
17. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
Rahman M; Jackson LK; Johnson WE; Li DY; Bild AH; Piccolo SR
Bioinformatics; 2015 Nov; 31(22):3666-72. PubMed ID: 26209429
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.
Hudson AM; Yates T; Li Y; Trotter EW; Fawdar S; Chapman P; Lorigan P; Biankin A; Miller CJ; Brognard J
Cancer Res; 2014 Nov; 74(22):6390-6396. PubMed ID: 25256751
[TBL] [Abstract][Full Text] [Related]
19. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
[TBL] [Abstract][Full Text] [Related]
20. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.
Han Y; Yang J; Qian X; Cheng WC; Liu SH; Hua X; Zhou L; Yang Y; Wu Q; Liu P; Lu Y
Nucleic Acids Res; 2019 May; 47(8):e45. PubMed ID: 30773592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
